Remove Article Remove Bioinformatics Remove Research
article thumbnail

Combination of Metabolomics and Bioinformatics to Reveal the Mechanism of Luteolin in the Treatment of Cervical Cancer

Chemical Biology and Drug Design

The remarkable therapeutic potential of luteolin against cervical cancer can be ascribed to its profound influence on amino acid and nucleotide metabolism, substantiated by the seamless integration of metabolomics, bioinformatics, and molecular docking techniques in this comprehensive investigation.

article thumbnail

Biological Characterization of One Oxadiazole Derivative (5(4‐Hydroxyphenyl)‐2‐(N‐Phenyl Amino)‐1,3,4‐Oxadiazole): In Vitro, In Silico, and Network Pharmacological Approaches

Chemical Biology and Drug Design

These results were confirmed by molecular modeling and bioinformatics tools. In the anticancer test, the compound showed strong anticancer activity in pancreatic cancer with apoptotic signaling pathways.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Screening and introduction of key cell cycle microRNAs deregulated in colorectal cancer by integrated bioinformatics analysis

Chemical Biology and Drug Design

Our data imply that a precise selection of bioinformatics tools can facilitate the identification of miRNAs that impact mRNA translation at different stages of the cell cycle. The ability of these six miRNAs to impact the cell cycle in colorectal cancer may be concluded.

article thumbnail

The first major set of genetic associations found in long COVID

Drug Target Review

The article mentions that TLR4 antagonists have been identified as potential candidates for repurposing long COVID treatment. We also identified the genes ATP9A and INSR in long COVID that we had hypothesised contributes to dysregulated insulin signalling in subgroups of ME/CFS patients.

article thumbnail

Therapeutic Oligos 2025 Keynote Speakers Announced

Elrig

There will also be a poster award for early-career professionals recognising the research that the next generation of scientists bring to drug discovery. Dr Andersson has authored over 70 peer-reviewed articles and is a named inventor on six patents.

RNA 59
article thumbnail

ANKRD22 promotes M2 polarization in lung adenocarcinoma macrophages via the glycolytic pathway

Chemical Biology and Drug Design

The expression of ANKRD22 in LUAD and its enriched pathway were analyzed by bioinformatics analysis. Bioinformatics analysis, qRT-PCR, and western blot showed that ANKRD22 was highly expressed in LUAD, which had a positive connection with M2 marker genes. Mitochondrial membrane potential was assessed using the JC-1 probe.

article thumbnail

Scientific workflow for hypothesis testing in drug discovery: Part 1

Drug Target Review

In drug discovery and biological research, the scientists workflow often follows a structured and iterative approach to ensure accuracy, reproducibility and scientific integrity. At the heart of any research is the scientific question. This acts as a safeguard against false positives and misinterpretation of the data.

RNA 52